Immediate Effects of Dry Needling and Tens in Chronic Neck Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02230709|
Recruitment Status : Completed
First Posted : September 3, 2014
Last Update Posted : September 21, 2016
|Condition or disease||Intervention/treatment||Phase|
|Myofascial Neck Pain||Other: Dry Needling Other: "TENS" and "dry needling"||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||IMMEDIATE EFFECTS OF DRY NEEDLING VERSUS DRY NEEDLING AND TENS ON PAIN IN PATIENTS WITH CHRONIC MIOFASCIAL NECK PAIN|
|Study Start Date :||November 2012|
|Actual Primary Completion Date :||November 2012|
Experimental: Dry needling
Dry needling treatment on the trigger point number 2 of the trapezius muscle.
Other: Dry Needling
Needling with acupuncture needle in a myofascial trigger point.
Active Comparator: "TENS" and "dry needling"
Application of TENS current after dry needling treatment.
Other: "TENS" and "dry needling"
Application of TENS current after dry needling technique
- Neck Pain [ Time Frame: 4 days ]Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).
- Post-needling pain [ Time Frame: 4 days ]Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).
- Pressure Pain threshold [ Time Frame: 4 days ]Pressure needed to evoke pain recognized by patient. Measured using an algometer in Kg/cm2
- Range of Motion [ Time Frame: 4 days ]The subjects sat in a chair and a CROM goniometer was placed over the head. They were asked to perform active neck movements to the fullest extent of their mobility. Each movement was recorded three times and the average value was calculated.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02230709
|CSEU La Salle|
|Aravaca, Madrid, Spain|